LENZ Therapeutics
LENZ
#9742
Rank
A$0.14 B
Marketcap
A$4.48
Share price
-11.23%
Change (1 day)
-90.21%
Change (1 year)

P/S ratio for LENZ Therapeutics (LENZ)

P/S ratio as of November 2026 (TTM): 7.40

According to LENZ Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4170. At the end of 2026 the company had a P/S ratio of 9.10.

P/S ratio history for LENZ Therapeutics from 2024 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20269.10-65.3%
202526.2
2024N/A